Literature DB >> 11751753

Functional expression of indoleamine 2,3-dioxygenase by murine CD8 alpha(+) dendritic cells.

Francesca Fallarino1, Carmine Vacca, Ciriana Orabona, Maria L Belladonna, Roberta Bianchi, Brendan Marshall, Derin B Keskin, Andrew L Mellor, Maria C Fioretti, Ursula Grohmann, Paolo Puccetti.   

Abstract

Immunoregulatory antigen-presenting cells (APC) play an important role in maintaining T cell homeostasis and self-tolerance. In particular, recent evidence demonstrates a role for inhibition of T cell proliferation by macrophage tryptophan catabolism involving the activity of the enzyme indoleamine 2,3-dioxygenase (IDO). Dendritic cells (DC) have also been shown to exert immunoregulatory effects mediated by tryptophan catabolism and to cause T cell apoptosis. In the present study, we have comparatively analyzed the expression of IDO activity by murine macrophages and splenic DC. By means of PCR, Western blotting and measurements of enzyme functional activity, we obtained evidence that, different from macrophages, DC constitutively express IDO. Following activation by IFN-gamma, the latter cells, in particular the CD8 alpha(+) subset, exhibit high functional activity and, unlike macrophages, mediate apoptosis of T(h) cells in vitro. Therefore, in the mouse, CD8 alpha(+) DC may be unique APC capable of fully expressing the IDO mechanism functionally.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11751753     DOI: 10.1093/intimm/14.1.65

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  83 in total

1.  Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division.

Authors:  Geon Kook Lee; Hyeon Jin Park; Megan Macleod; Phillip Chandler; David H Munn; Andrew L Mellor
Journal:  Immunology       Date:  2002-12       Impact factor: 7.397

Review 2.  Dendritic cells, T cell tolerance and therapy of adverse immune reactions.

Authors:  P A Morel; M Feili-Hariri; P T Coates; A W Thomson
Journal:  Clin Exp Immunol       Date:  2003-07       Impact factor: 4.330

Review 3.  Identification and characterization of CD8+ suppressor T cells.

Authors:  James C Zimring; Judith A Kapp
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 4.  New insights into the functional role of the rheumatoid arthritis shared epitope.

Authors:  Denise E de Almeida; Song Ling; Joseph Holoshitz
Journal:  FEBS Lett       Date:  2011-03-22       Impact factor: 4.124

5.  Long-term effects of IFN-gamma, IL-10, and TGF-beta-modulated dendritic cells on immune response in Lewis rats.

Authors:  Rui-Sheng Duan; Hans Link; Bao-Guo Xiao
Journal:  J Clin Immunol       Date:  2005-01       Impact factor: 8.317

6.  ANALYSIS OF DENDRITIC CELL STIMULATION UTILIZING A MULTI-FACETED NANOPOLYMER DELIVERY SYSTEM AND THE IMMUNE MODULATOR 1-METHYL TRYPTOPHAN.

Authors:  Kevin P Nikitczuk; Edmund C Lattime; Rene S Schloss; Martin L Yarmush
Journal:  Nano Life       Date:  2010-09-01

Review 7.  IDO-expressing regulatory dendritic cells in cancer and chronic infection.

Authors:  Alexey Popov; Joachim L Schultze
Journal:  J Mol Med (Berl)       Date:  2007-09-18       Impact factor: 4.599

8.  CD4 T cells differentially express cellular machinery for serotonin signaling, synthesis, and metabolism.

Authors:  Hera Wu; DeVon Herr; Nancie J MacIver; Jeffrey C Rathmell; Valerie A Gerriets
Journal:  Int Immunopharmacol       Date:  2020-08-28       Impact factor: 4.932

9.  Immunomodulatory effects of vitamin D: implications for GVHD.

Authors:  J Rosenblatt; A Bissonnette; R Ahmad; Z Wu; B Vasir; K Stevenson; C Zarwan; W Keefe; B Glotzbecker; H Mills; R Joyce; J D Levine; D Tzachanis; V Boussiotis; D Kufe; D Avigan
Journal:  Bone Marrow Transplant       Date:  2010-01-18       Impact factor: 5.483

10.  Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes.

Authors:  David H Munn; Madhav D Sharma; Deyan Hou; Babak Baban; Jeffrey R Lee; Scott J Antonia; Jane L Messina; Phillip Chandler; Pandelakis A Koni; Andrew L Mellor
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.